Agility in Manufacturing Preparedness Act
Summary
Agility in Manufacturing Preparedness Act This bill requires the Department of Health and Human Services (HHS) to seek to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals to assess and make recommendations concerning U.S. capabilities for biopharmaceutical manufacturing and related matters. HHS must coordinate with the Biomedical Advanced Research and Development Authority on this contract.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2022
Committee Review
Floor Vote
President
Introduced Feb 2, 2022
Last action Feb 2, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Feb 2, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Feb 2, 2022
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3553
Scope: US
Hi! I can help you understand S 3553. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline